Expansion comes after IntelliSep® helped reduce the risk-adjusted sepsis mortality index by 30% in first hospital deployment SAN FRANCISCO, Oct. 30, 2024 /PRNewswire/ — Cytovale®, a commercial-stage medical diagnostics company focused on advancing early detection technologies to diagnose…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.